For residents of Massachusetts, this coming spring will be a time to breathe in relief as the state's first medical marijuana dispensaries open their doors. Alternative Therapies Group (aka: ATG) was the first in the state to recieve it's license to grow and sell medical marijuana. Many other dispensaries will be opening this year as well to take part in the growing economic opportunities brought on by legal pot. The Department of Public Health handed down the license on Wednesday, December 31, to ATG which will be located in Salem, Mass. with a cultivation facility in Amesbury, Mass. According to a note posted on ATG's website, the dispensary "will begin cultivating cannabis immediately and hope to be in a position to start dispensary operations by Spring 2015."
Despite Obama's recent legislation prohibiting federal interference with state medical marijuana laws, his administration insists that marijuana stay a Schedule 1 substance next to heroin, ecstasy and LSD. Although 23 states currently have legal medical marijuana programs, some insist there is still no medical value to the plant. Defendants argue that many studies have been done proving benifits of marijuana, but the government refuses to approve such studies, as well as refusing independant researchers. While there may be “some dispute among doctors as to whether marijuana is medicine,” there is ample evidence to support the government’s conclusion that “this psychoactive, addictive drug is not accepted as safe for medical use at this time, even with medical supervision,” Assistant U.S. Attorney Gregory Broderick wrote.
This coming session, Tallian hopes a more narrowly defined bill to legalize marijuana for people with certain medical conditions would fare better in a Republican-controlled legislature. The bill that she plans to introduce would allow people with a medical marijuana card and a doctor's recommendation to use marijuana. The National Conference of State Legislatures reports 23 states allow comprehensive medical marijuana programs. But the Drug Enforcement Agency still classifies the narcotic as dangerous, saying it shouldn’t be used medically. And that grabs the attention of some Indiana republicans who control the Statehouse. “For me the issue is not an issue of budget or case or those things,” State Sen. Luke Kenley (R-Noblesville) said. “I think the issue needs to be decided on the merits of whether it’s advisable for us to proceed in that direction. I’m a skeptic in that regards, but I’ll leave open a little room for Sen. Tallian to try to persuade me.”
A bill introduced in Congress would allow Department of Veterans Affairs doctors to recommend medical marijuana for their patients. “Post traumatic stress and traumatic brain injury are just as damaging and harmful as any injuries that are visible from the outside,” said Blumenauer, the bill’s author. “Sometimes even more so because of the devastating effect they can have on a veteran’s family. We should be allowing these wounded warriors access to the medicine that will help them survive and thrive, including medical marijuana, not treating them like criminals and forcing them into the shadows. It’s shameful.” The VEAA is cosponsored by a balanced mix of ten members on each side of the aisle, as well as a range of members from states that have, and still have not, legalized marijuana for medical use: Dina Titus (D-NV), Justin Amash (R-MI), Paul Broun (R-GA), Walter Jones (R-NC), Thomas Massie (R-KY), Sam Farr (D-CA), Jared Polis (D-CO), Beto O’Rourke (D-TX), Steve Stockman (R-TX) and Steve Cohen (D-TN).
America is in the middle of a Marijuana Revolution. With companies lining up to jump on the medical marijuana bandwagon. The patent, called “Cannabinoids as Antioxidants and Neuroprotectants,” was quietly filed in 2005 when scientists from the NIH found certain cannabis compounds had neuroprotectant properties, “for example, in limiting neurological damage following ischemic insults, such as stroke or trauma, or the treatment of neurological diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.” “I think the [NIH wanted] a public-private partnership … the government does a good job of using taxpayer dollars to foster research and development, and NIH is the largest laboratory of its kind in the world in terms of scientific research and development,” Dean Petkanas, CEO of KannaLife Sciences told FoxNews.com. “They don't want to develop drugs, but they'd like private interest such as ours to step up to the plate and say ‘We're gonna take some risk with you.’”
Vanita Gupta, the current director for the ACLU's Center for Justice is poised to take the lead of the civil rights division of the Justice Department. What's more, Gupta is a strong advocate for ending the war on drugs, decriminalizing marijuana and even legalization in states. "This country has spent 40 years relentlessly ratcheting up the number of people going to prison and dramatically expanding the time we hold them there," she writes. "We've spent decades criminalizing people with drug dependency, passing extreme sentencing laws, and waging a war on drugs that has not diminished drug use."
Maryland's medical marijuana program has been put on hold before a final vote due to adjustments to licensing fees and legalization of marijuana extracts. Dr. Paul W. Davies, a chairman on the panel stated that officals are requesting more time to draft rules pertaining to concentrated forms of marijuana. "We realized that our regulations didn't cover extracts," said Davies, a pain management specialist, "and for medical use that's incredibly important." The commission had opted initially to focus only on growing and dispensing marijuana in leaf form, Davies said, because of the "time crunch" of meeting a Sept. 15 deadline set by the General Assembly for adopting regulations. But the panel decided to respond to public comments urging it to include extracts, he said, because for some people dosing themselves by smoking marijuana isn't feasible or comfortable.
In March, one mother traveled to Colorado to get a bottle of cannabis oil in hopes of easing the agonizing pain her 15-year-old son has lived with for the past three years. What she calls a mother's instinct may land her in jail, reports CBS News correspondent Adriana Diaz. "I broke the law, but I did it to save my son," Angela Brown said. For years, the Minnesota mom searched for a way to end her son's chronic pain. Trey appeared healthy, but a baseball accident in 2011 led to a build-up of pressure inside his head.
Competition among medical marijuana businesses in Illinois will be intense after more than 350 groups applied to legally grow or sell the state's first legal and taxed cannabis, program officials announced Wednesday. A preliminary count showed 158 applications for cultivation centers and 211 applications for dispensaries beat the Monday afternoon deadline. That means that nonrefundable fees collected by the state from the applicants topped $5 million. "There's a ton of excitement and enthusiasm from the industry," said one applicant, Ben Kovler, founding partner and CEO of Chicago-based Green Thumb Industries. "This shows there is trust in the system the state has set up." Green Thumb submitted applications for cultivation centers in Normal, Rock Island, Oglesby and Dixon and dispensaries in Mundelein, Chicago and Chicago Heights, Kovler said. Applications were so extensive that they filled many boxes and required the company to rent a truck, he said. Bob Morgan, coordinator of the state's medical cannabis program, said the volume of applications "will allow us to pick the most qualified applicants."
The international Cannabis Association is putting on the world's leading cannabis business expo in New York City. This East Coast cannabis expo will feature educational conferences, speakers, and a regulatory summit. Entrepreneurs, business professionals, and lawmakers will have a chance to rub elbows at the largest expo on the east coast, which will feature more than 80 exhibitors and 40 speakers. If you are seeking a new business opportunity in the cannabis industry, then you cannot miss this event. As one of the fastest growing industries in the U.S., entrepreneurs are recognizing the opportunity to get in early- now is the time to take advantage. Attendees will have the opportunity to get connected with other cannabis-related business professionals to help their businesses grow, or launch their own start-up. The ICA caters to both business owners and investors to help achieve success and identify new expansion points in the cannabis industry. This event will sell out, so get your ticket as early as possible. Save 20% on your registration fees by using the coupon code WHERESWEED at checkout on internationalcannabisassociation.com. The event will take place October 11-13th at the Marriott Marquis Hotel in Times Square, NYC.
(CNN) -- Think of psychedelics and you'll likely think of bright colors, hallucinations, spirituality, and an overall "mystical" experience. For centuries these drugs have been used in social, religious and medicinal contexts by cultures across the globe. But today, the ability of these drugs to alter our brain function is being tapped into as a potential therapeutic for a range of mental health conditions from anxiety and depression to addiction and obsessive compulsive disorder (OCD). "Only by losing the self, can you find the self," explains Dr Robin Carhart-Harris, from Imperial College London. These may not be the usual words of a scientist but there is biology behind them. "People try and run away from things and to forget, but with psychedelic drugs they're forced to confront and really look at themselves," he says.
Recognizing the potential value of medical cannabis for treating some serious conditions, the Dayton Administration, lawmakers and advocates worked together to develop a compromise that allows suffering Minnesotans to use medical cannabis in a safe manner. ST. PAUL, Minn. (AP) — The state of Minnesota has begun taking applications from entrepreneurs interested in opening medical cannabis manufacturing facilities, and the potential applicants include members of the family that owns Bachman’s Inc., the Minneapolis-based chain of floral and garden shops. “There are several family members that are interested,” company spokeswoman Karen Bachman said Friday as the application period opened. She declined to identify which family members might apply and stressed that the company itself is not interested